Showing results (31-40 of 224) with videos related to
Sort By:
Pageof 23
Methods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Lupus anticoagulant testingKaren Moffat, Anne Raby, Mark CrowtherArchives of Internal Medicine|December 3, 2002
Is impaired renal function a contraindication to the use of low-molecular-weight heparin?Jeff Nagge, Mark Crowther, Jack HirshSeminars in Hematology|May 14, 2013
Thrombopoietin receptor agonists in primary immune thrombocytopeniaDeborah Siegal, Mark Crowther, Adam CukerMethods in Molecular Biology (Clifton, N.J.)|April 3, 2013
Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assaysAnne Raby, Karen Moffat, Mark CrowtherBMJ Evidence-Based Medicine|June 5, 2020
Evaluating the quality of systematic reviews and meta-analyses published on direct oral anticoagulants in the past 5 yearsAli Eshaghpour, Allen Li, Arshia Pedram Javidan, et al.Blood|January 7, 2006
Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysisFrancesco Dentali, Mark Crowther, Walter AgenoPharmacoeconomics|June 10, 2006
Dalteparin versus warfarin for the prevention of recurrent venous thromboembolic events in cancer patients: a pharmacoeconomic analysisGeorge Dranitsaris, Mark Vincent, Mark CrowtherResearch and Practice in Thrombosis and Haemostasis|April 17, 2023
Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosingThita Chiasakul, Mark Crowther, Adam CukerBMJ Evidence-Based Medicine|October 1, 2020
Quality of early evidence on the pathogenesis, diagnosis, prognosis and treatment of COVID-19Sarah Yang, Allen Li, Ali Eshaghpour, et al.Blood|July 27, 2010
Systematic review and meta-analysis methodologyMark Crowther, Wendy Lim, Mark A CrowtherPageof 23